For instance, identifying key genes such as GRIN3A and their associated pathways, including NMDA receptor signaling, unveils new avenues for targeted therapies aimed at modulating these pathways to mitigate or arrest AD progression. The gene discussed is GRIN3A; the disease is Alzheimer disease.